Verrica Pharmaceuticals’ YCANTH Receives New Chemical Entity Status, Orange Book Listing From FDA
Verrica Pharmaceuticals Inc.’s YCANTH now has New Chemical Entity (NCE) Status and a listing in the Orange Book from the U.S. Food and Drug Administration (FDA), providing a minimum five years of regulatory exclusivity. YCANTH (cantharidin) topical solution, 0.7% is indicated for the topical treatment of molluscum contagiosum in adult and pediatric patients aged 2 […]